Ali Rıza AKIN began his scientific career at the University of Istanbul, Biology Department, where he worked on human microbiota, next-generation probiotics, and host-microbe relationships for 25 years. He continued his research journey in Northern California, Silicon Valley. In particular, he led a team that made groundbreaking discoveries of dozens of new-generation bacteria worldwide in the last 10 years. His microbiota studies, especially regarding the impact of bacteria on human health and creative solutions like appetite control with probiotics, have opened up new horizons in his research. Furthermore, he is also among the authors of the book 'Bacterial Therapy of Cancer' written in collaboration with some of the world's leading scientists in the field.
His work in the United States has been carried out in collaboration with research centers such as UCLA, Imperial College of London, University of Manchester, University of Groningen, University College Cork, Bill and Melinda Gates Foundation, and Novartis Biomedical Research Institute. Along with patented inventions in Europe, Japan, and America, he has also filed patents for “Treatment of Metabolic Diseases with Next-Generation Bacteria”.
Ali Rıza AKIN was the first to introduce highly effective products based on systems developed for the Akkermansia and Christensenella families, the most famous among the next-generation probiotics. These products are aimed at controlling hunger hormones, eliminating insulin resistance, weight loss, eliminating stress-depression, and alleviating menstrual pain using new generation prebiotics. They were first introduced in Turkey and were made available through private health insurances in the United States in 2022.
Ali R. Akın's latest project involves creating a product incorporating hundreds of new-generation probiotic strains under the same concept. This project aims to put an end to fecal transplantation in the world. In the 21st century, Ali Rıza Akın is paving new paths in Anaerobic Microbiology studies, opening up exciting new perspectives on human health.
One of the most famous figures in the field of new generation probiotics, Ali R. Akın, is currently actively serving as a scientific consultant in California's Silicon Valley and at Next Microbiome company.
